Search
for
Sort by
Research 751–780 of 1000+
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial
- How to Assess Dermatology Resident Surgical Training: New Techniques
- FUE for the repair of unnaturally designed or low hairlines in men with androgenetic alopecia: a retrospective, multicenter observational study
- Micro-needling: current state of knowledge and clinicalapplications: a review
- Signaling pathways in hair aging
- Assessing the Environmental and Health Adverse Effects of Mercury Released From Dental Amalgam: A Literature Review
- Contents
- Relapsing nail fibrokeratoma: A case report on a teenager
- withdrawn
- Hair Restoration with the Erbium YAG Laser
- A 20-year retrospective clinicopathologic study on melanoma in Singapore
- Essentials of Aesthetic Surgery Jeffery J. Janis
- Avoiding pitfalls in planning a hair transplant
- A matter of life and death: self‐renewal in stem cells
- Stromal vascular fraction‐enriched platelet‐rich plasma therapy reverses the effects of androgenetic alopecia
- Safe and Effective Conscious Sedation Administered by Dermatologic Surgeons
- Selection of Anti-Depressants in Geriatric Dermatoses- A Questionnaire Study of Dermatologists in Western Rajasthan, India
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- Use of low-level laser therapy as monotherapy or concomitant therapy for male and female Androgenetic alopecia
- Growth factor mimetics for skin regeneration: In vitro profiling of primary human fibroblasts and keratinocytes
- Metallic glass coating for improved needle tattooing performance in reducing trauma: analysis on porcine and pig skins
- Patients treated with thinner artificial hair implants: a case series
- Telogen effluvium and associated incidence of abnormal serum ferritin, zinc, 25-hydroxy vitamin D, and thyroid-stimulating hormone
- Safety and efficacy of tavaborole (AN2690), a novel boron-based molecule, in 3 phase II trials for the topical treatment of toenail onychomycosis
- Pressure Alopecia in a Pediatric Patient: A Case Report
- Effect of decellularisation methods on methacryloyl-substituted placental ECM hydrogels
- Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period
- Review of applications of microneedling in dermatology
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection